Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2374-4677
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer ; volume:8 ; number:1 ; day:11 ; month:7 ; year:2022 ; pages:1-7 ; date:12.2022
npj Breast cancer ; 8, Heft 1 (11.7.2022), 1-7, 12.2022
- Urheber
-
Yoder, Rachel
Kimler, Bruce F.
Staley, Joshua M.
Schwensen, Kelsey
Wang, Yen Y.
Finke, Karissa
O’Dea, Anne
Nye, Lauren
Elia, Manana
Crane, Gregory
McKittrick, Richard
Pluenneke, Robert
Madhusudhana, Sheshadri
Beck, Larry
Shrestha, Anuj
Corum, Larry
Marsico, Mark
Stecklein, Shane R.
Godwin, Andrew K.
Khan, Qamar J.
Sharma, Priyanka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-022-00448-4
- URN
-
urn:nbn:de:101:1-2022091408573612198088
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yoder, Rachel
- Kimler, Bruce F.
- Staley, Joshua M.
- Schwensen, Kelsey
- Wang, Yen Y.
- Finke, Karissa
- O’Dea, Anne
- Nye, Lauren
- Elia, Manana
- Crane, Gregory
- McKittrick, Richard
- Pluenneke, Robert
- Madhusudhana, Sheshadri
- Beck, Larry
- Shrestha, Anuj
- Corum, Larry
- Marsico, Mark
- Stecklein, Shane R.
- Godwin, Andrew K.
- Khan, Qamar J.
- Sharma, Priyanka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study
Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes
Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis
Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report
New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study
Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes
Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis
Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report
New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study
Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes
Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis
Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report